Education
About Us
Working with TipRanks
Follow Us
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
RESEARCH TOOLSreports
Technical Sentiment
Overall Consensus
Sell
5Bullish
6Neutral
11Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
NewAmsterdam Pharma Company’s (NAMS) Moving Averages Convergence Divergence (MACD) indicator is -1.30, suggesting NewAmsterdam Pharma Company is a Sell.
NewAmsterdam Pharma Company’s (NAMS) 20-Day exponential moving average is 17.59, while NewAmsterdam Pharma Company’s (NAMS) share price is $16.79, making it a Sell.
NewAmsterdam Pharma Company’s (NAMS) 50-Day exponential moving average is 19.44, while NewAmsterdam Pharma Company’s (NAMS) share price is $16.79, making it a Sell.
NewAmsterdam Pharma Company (NAMS) Pivot Points
Classic
15.08
15.64
16.22
16.77
17.35
17.91
18.48
Fibonacci
15.64
16.07
16.34
16.77
17.21
17.47
17.91
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
NewAmsterdam Pharma Company (NAMS) Moving Averages
MA5
16.54Buy
16.67Buy
MA10
16.11Buy
16.67Buy
MA20
17.48Sell
17.59Sell
MA50
19.92Sell
19.44Sell
MA100
21.55Sell
20.31Sell
MA200
19.91Sell
19.84Sell
NewAmsterdam Pharma Company’s (NAMS) 10-Day exponential moving average is 16.67, while NewAmsterdam Pharma Company’s (NAMS) share price is $16.79, making it a Buy.
NewAmsterdam Pharma Company’s (NAMS) 100-Day exponential moving average is 20.31, while NewAmsterdam Pharma Company’s (NAMS) share price is $16.79, making it a Sell.
NewAmsterdam Pharma Company’s (NAMS) stock price is $16.79 and NewAmsterdam Pharma Company’s (NAMS) 50-day simple moving average is 19.92, creating a Sell signal.
NewAmsterdam Pharma Company’s (NAMS) stock price is $16.79 and NewAmsterdam Pharma Company’s (NAMS) 100-day simple moving average is 21.55, creating a Sell signal.
NewAmsterdam Pharma Company’s (NAMS) stock price is $16.79 and NewAmsterdam Pharma Company’s (NAMS) 200-day simple moving average is 19.91, creating a Sell signal.
NewAmsterdam Pharma Company (NAMS) Technical Indicators
RSI (14)
43.59
Neutral
STOCH (9,6)
79.66
Neutral
STOCHRSI (14)
58.21
Neutral
MACD (12,26)
-1.30
Sell
ADX (14)
33.40
Neutral
Williams %R
-19.14
Sell
CCI (14)
-11.37
Neutral
ATR (14)
1.34
-
Ultimate Oscillator
53.41
Neutral
ROC
-5.16
Sell
NewAmsterdam Pharma Company’s (NAMS) Relative Strength Index (RSI) is 43.59, creating a Neutral signal.
NewAmsterdam Pharma Company’s (NAMS) Trend Strength Indicator (ADX) is 33.40, creating a Neutral signal.
NewAmsterdam Pharma Company’s (NAMS) Commodity Channel Index (CCI) is -11.37, creating a Neutral signal.
NewAmsterdam Pharma Company’s (NAMS) Price Rate of Change (ROC) is -5.16, creating a Sell signal.
FAQ
Is NAMS a Buy, Hold, or Sell?
Based on NAMS’s technical indicators, NAMS is a Sell.
What is NAMS’s RSI (14)?
NAMS’s RSI (14) is 43.59, which suggests NAMS is a Neutral.
What is NAMS’s MACD?
NAMS’s MACD is -1.30, which suggests NAMS is a Sell.
What is NAMS’s 5-day moving average?
NAMS’s 5-day moving average is 16.54, which suggests NAMS is a Buy.
What is NAMS’s 20-day moving average?
NAMS 20-day moving average is 17.48, which suggests NAMS is a Sell.
What is NAMS’s 50-day moving average?
NAMS’s 50-day moving average is 19.92, which suggests NAMS is a Sell.
What is NAMS’s 200-day moving average?
NAMS’s 200-day moving average is 19.91, which suggests NAMS is a Sell.
What is NAMS’s Williams % R (14)?
NAMS’s Williams % R (14) is -19.14, which suggests NAMS is a Sell.
What is NAMS’s CCI (14)?
NAMS’s CCI (14) is -11.37, which suggests NAMS is a Neutral.